Reported figures and Equlion model projections for the next 5 years.
ROE
+613.4 pt
Company
ROA
-347.6 pt
Company
Total Assets
-95.5%
Company
Sector average (own scale)
Net Income
-15%
Company
Sector average
Detailed data
AUD
Amounts in AUD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for NEURIZON THERAPEUTICS LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.